"Isala is een groot regioziekenhuis. Woont u in de regio, dan is Isala – met vijf locaties in Zwolle, Meppel, Steenwijk, Kampen en Heerde – uw ziekenhuis bij gezondheidsproblemen. Voor complexe zorg komen ook mensen uit omliggende ziekenhuizen en ver daarbuiten naar Isala. In Isala zorgen we niet alleen voor u, maar doen we dat samen met u. Samen komen we tot de juiste behandeling."

During the past decade, Isala Klinieken - locatie Weezenlanden conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Isala Klinieken - locatie Weezenlanden" #1 sponsor was "Eli Lilly and Company" with 4 trials, followed by "European Organisation for Research and Treatment of Cancer - EORTC" with 2 trials sponsored, "Medtronic Cardiac Rhythm and Heart Failure" with 2 trials sponsored, "Abbott Medical Devices" with 1 trials sponsored and "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Isala Klinieken - locatie Weezenlanden" #1 collaborator was "Arbeitsgemeinschaft fur Internistische Onkologie" with 1 trials as a collaborator, "Australasian Leukaemia and Lymphoma Group" with 1 trials as a collaborator, "Dutch Colorectal Cancer Group (DCCG)" with 1 trials as a collaborator, "EORTC GI Group (EORTC 40023)" with 1 trials as a collaborator and "Egyptian Foundation For Cancer Research" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Isala Klinieken - locatie Weezenlanden" are "Colorectal Cancer" (2 trials), "Coronary Artery Disease" (2 trials), "Migraine" (2 trials), "Chronic Migraine" (1 trials) and "Complete Tear, Knee, Anterior Cruciate Ligament" (1 trials). Many other conditions were trialed in "Isala Klinieken - locatie Weezenlanden" in a lesser frequency.

Most popular intervention types in "Isala Klinieken - locatie Weezenlanden" are "Drug" (7 trials), "Device" (4 trials), "Procedure" (3 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Galcanezumab" (2 trials), "Lasmiditan" (2 trials), "CHOP regimen" (1 trials) and "Clopidogrel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Isala Klinieken - locatie Weezenlanden" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Isala Klinieken - locatie Weezenlanden". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Isala Klinieken - locatie Weezenlanden, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Isala Klinieken - locatie Weezenlanden, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".